Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.'
1 Pharmacovigilance and Epidemiology Department, Inspections Human Medicines Pharmacovigilance and Committees Division, European Medicines Agency (EMA), London, E14 5EU, UK.
2 Division of Population Health Sciences, University of Dundee, Dundee, DD2 4BF, UK.